ID

21784

Descripción

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00299104

Link

https://clinicaltrials.gov/show/NCT00299104

Palabras clave

  1. 30/4/17 30/4/17 -
Subido en

30 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Rheumatoid Arthritis NCT00299104

Eligibility Rheumatoid Arthritis NCT00299104

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients 18-80 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ra for ≥ 2 months;
Descripción

Rheumatoid Arthritis: Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0872146
UMLS CUI [1,2]
C0003873
receiving outpatient treatment
Descripción

Outpatient

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029921
patients naive to, and considered to be candidates for, methotrexate treatment
Descripción

Methotrexate Treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0746573
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
rheumatic autoimmune disease other than ra, or significant systemic involvement secondary to ra
Descripción

Rheumatic autoimmune disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0035435
inflammatory joint disease other than ra, or other systemic autoimmune disorder
Descripción

Inflammatory joint disease or systemic autoimmune disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0683381
UMLS CUI [2]
C1384868
diagnosis of juvenile rheumatoid arthritis, or ra before the age of 16
Descripción

Juvenile rheumatoid arthritis or age of onset

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0311221
UMLS CUI [2]
C0206132
surgery within 12 weeks of study
Descripción

Surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0543467
previous treatment with any approved or investigational biologic agent for ra, an anti-alpha4-integrin antibody or co-stimulation modulator, or cell-depleting therapy
Descripción

Prior treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514463
concurrent treatment with any biologic agent or dmard other than methotrexate
Descripción

Concurrent treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013227

Similar models

Eligibility Rheumatoid Arthritis NCT00299104

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
adult patients 18-80 years of age
boolean
C0001779 (UMLS CUI [1])
Rheumatoid Arthritis: Duration
Item
ra for ≥ 2 months;
boolean
C0872146 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
Outpatient
Item
receiving outpatient treatment
boolean
C0029921 (UMLS CUI [1])
Methotrexate Treatment
Item
patients naive to, and considered to be candidates for, methotrexate treatment
boolean
C0746573 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Rheumatic autoimmune disease
Item
rheumatic autoimmune disease other than ra, or significant systemic involvement secondary to ra
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
Inflammatory joint disease or systemic autoimmune disorder
Item
inflammatory joint disease other than ra, or other systemic autoimmune disorder
boolean
C0683381 (UMLS CUI [1])
C1384868 (UMLS CUI [2])
Juvenile rheumatoid arthritis or age of onset
Item
diagnosis of juvenile rheumatoid arthritis, or ra before the age of 16
boolean
C0311221 (UMLS CUI [1])
C0206132 (UMLS CUI [2])
Surgery
Item
surgery within 12 weeks of study
boolean
C0543467 (UMLS CUI [1])
Prior treatment
Item
previous treatment with any approved or investigational biologic agent for ra, an anti-alpha4-integrin antibody or co-stimulation modulator, or cell-depleting therapy
boolean
C1514463 (UMLS CUI [1])
Concurrent treatment
Item
concurrent treatment with any biologic agent or dmard other than methotrexate
boolean
C0013227 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial